title: Melatonin as a potential therapeutic agent in psychiatric illness.
abstract: The aim of this review was to summarize the potential use of melatonin in the treatment of mental disorders, specifically bipolar disorders, depression, and schizophrenia. To date, melatonin has been most commonly used in psychiatry because of its hypnotic, rhythm resynchronizing, and antioxidant actions. Here, we examine other properties of the melatonin including its anti-inflammatory, antinociceptive, anxiolytic, and drug detoxification actions as well as its protective effects against neural loss. The brain is an intricate sensory and motor organ which receives information from both the external and internal environments. It transduces information into complex chemical and electrical signals which are transmitted throughout the central nervous system (CNS) and the organism. The pathogenesis of mental disorders remains ambiguous and neuroinflammation has been proposed as a causative agent. We consider the potential contributions of melatonin as therapeutic agent in CNS and during neuroinflammation in mental disorders.
authors: Department of Medical Biochemistry and Molecular Biology, University of Seville Medical School, Seville, Spain. aibar@us.es
authors: Maria D
authors: MD
authors: Maldonado
authors: Russel J
authors: RJ
authors: Reiter
authors: Maria A
authors: MA
authors: Pérez-San-Gregorio
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D006801:Humans; D008550:Melatonin / Q000627:therapeutic use*; D001523:Mental Disorders / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000975:Antioxidants; D008550:Melatonin